Sedana Medical AB Statistics

Total Valuation

Sedana Medical AB has a market cap or net worth of SEK 1.88 billion. The enterprise value is 1.66 billion.

Market Cap	1.88B
Enterprise Value	1.66B

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Sedana Medical AB has 99.34 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	99.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.02%
Owned by Institutions (%)	41.95%
Float	67.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.82
PB Ratio	1.98
P/TBV Ratio	1.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-29.07
EV / Sales	9.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-144.78

Financial Position

The company has a current ratio of 6.91, with a Debt / Equity ratio of 0.01.

Current Ratio	6.91
Quick Ratio	5.65
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.63
Interest Coverage	-249.48

Financial Efficiency

Return on equity (ROE) is -5.85% and return on invested capital (ROIC) is -3.41%.

Return on Equity (ROE)	-5.85%
Return on Assets (ROA)	-3.27%
Return on Capital (ROIC)	-3.41%
Revenue Per Employee	2.23M
Profits Per Employee	-733,885
Employee Count	79
Asset Turnover	0.17
Inventory Turnover	1.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.35% in the last 52 weeks. The beta is 0.22, so Sedana Medical AB's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-35.35%
50-Day Moving Average	14.78
200-Day Moving Average	20.09
Relative Strength Index (RSI)	70.60
Average Volume (20 Days)	613,098

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sedana Medical AB had revenue of SEK 174.14 million and -57.24 million in losses. Loss per share was -0.58.

Revenue	174.14M
Gross Profit	122.95M
Operating Income	-53.64M
Pretax Income	-56.53M
Net Income	-57.24M
EBITDA	-52.00M
EBIT	-53.64M
Loss Per Share	-0.58

Full Income Statement

Balance Sheet

The company has 226.39 million in cash and 7.24 million in debt, giving a net cash position of 219.15 million or 2.21 per share.

Cash & Cash Equivalents	226.39M
Total Debt	7.24M
Net Cash	219.15M
Net Cash Per Share	2.21
Equity (Book Value)	949.99M
Book Value Per Share	9.56
Working Capital	264.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.27 million and capital expenditures -1.22 million, giving a free cash flow of -11.50 million.

Operating Cash Flow	-10.27M
Capital Expenditures	-1.22M
Free Cash Flow	-11.50M
FCF Per Share	-0.12

Full Cash Flow Statement

Margins

Gross margin is 70.60%, with operating and profit margins of -30.80% and -32.87%.

Gross Margin	70.60%
Operating Margin	-30.80%
Pretax Margin	-32.46%
Profit Margin	-32.87%
EBITDA Margin	-29.86%
EBIT Margin	-30.80%
FCF Margin	n/a

Dividends & Yields

Sedana Medical AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.04%
FCF Yield	-0.61%

Stock Splits

The last stock split was on May 26, 2021. It was a forward split with a ratio of 4.

Last Split Date	May 26, 2021
Split Type	Forward
Split Ratio	4

Scores

Sedana Medical AB has an Altman Z-Score of 25.78.

Altman Z-Score	25.78
Piotroski F-Score	n/a